FLQL - Franklin LibertyQ U.S. Equity ETF
Assets | $1.55B |
NAV | $41.51 |
Expense Ratio | 0.15% |
PE Ratio | 26.08 |
Beta (5Y) | 0.90 |
Dividend (ttm) | $0.78 |
Dividend Yield | 1.87% |
Ex-Dividend Date | Mar 11, 2021 |
1-Year Return | - |
Trading Day | April 21 |
Last Price | $41.84 |
Previous Close | $41.51 |
Change ($) | 0.33 |
Change (%) | 0.80% |
Day's Open | 41.51 |
Day's Range | 41.51 - 41.86 |
Day's Volume | 24,180 |
52-Week Range | 28.32 - 41.89 |
Fund Description
The investment seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the LibertyQ U.S. Large Cap Equity Index (the U.S. Large Cap underlying index). Under normal market conditions, the fund invests at least 80% of its assets in the component securities of the U.S. Large Cap underlying index. The U.S. Large Cap underlying index is based on the Russell 1000® Index using a methodology developed with Franklin Templeton to reflect Franklin Templeton's desired investment strategy.
Asset Class Equity | Sector Large Cap |
Region North America | Inception Date Apr 26, 2017 |
Exchange BATS | Ticker Symbol FLQL |
Index Tracked LibertyQ U.S. Large Cap Equity Index |
Top 10 Holdings
11.33% of assetsName | Symbol | Weight |
---|---|---|
Applied Materials | AMAT | 1.39% |
Lam Research | LRCX | 1.21% |
Eli Lilly | LLY | 1.17% |
Intel | INTC | 1.15% |
Philip Morris | PM | 1.11% |
Estée Lauder | EL | 1.07% |
Microsoft | MSFT | 1.07% |
Cisco Systems | CSCO | 1.07% |
UnitedHealth | UNH | 1.05% |
Amgen | AMGN | 1.04% |
Dividends
Ex-Dividend | Amount | Pay Date |
---|---|---|
Mar 11, 2021 | $0.130723 | Mar 19, 2021 |
Dec 14, 2020 | $0.235426 | Dec 23, 2020 |
Sep 14, 2020 | $0.304347 | Sep 23, 2020 |
Jun 11, 2020 | $0.106988 | Jun 22, 2020 |
Mar 11, 2020 | $0.107597 | Mar 20, 2020 |
Dec 30, 2019 | $0.00743 | Jan 8, 2020 |
Style Box ETF report for FLQL
After an astounding rally for the past couple of months, Wall Street is stuck in a vicious circle of volatility caused by fears of a second wave of coronavirus cases and the Fed's grim economic outlook.